Earlier MD Anderson investigations demonstrated exosomes as a factor in detecting pancreatic cancer, but these latest findings reveal genetically
altered exosomes as a potentially novel approach for direct and specific targeting of mutated KRAS, the cancer
gene commonly linked to pancreatic cancer.